Shu-ichi Ikeda

6.1k citations

42 papers · 3.1k indexed · 2 hit papers · h-index 24

Molecular Biology top 2%
Physiology top 2%
Cell Biology top 2%
Oncology top 10%
Nephrology top 1%

Co-authors: Merrill D. Benson Giampaolo Merlini Per Westermark Maria João Saraiva Joel N. Buxbaum Jean D. Sipe Yukio Ando Gen Sobue
Topics: Amyloidosis: Diagnosis, Treatment, Outcomes (23 papers)Alzheimer's disease research and treatments (10 papers)Cellular transport and secretion (8 papers)
Cited by: Nephrology Molecular Biology Physiology
Journals: Circulation Brain Neurology
Partner nations: Japan United States Sweden

In The Last Decade

Shu-ichi Ikeda

42 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guideline of transthyretin-related hereditary amyloidosis for clinicians

2013 493 citations Yukio Ando, Teresa Coelho et al. Orphanet Journal of Rare Diseases profile →
Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines

2016 438 citations Jean D. Sipe, Merrill D. Benson et al. Amyloid profile →

Peers

Countries citing papers authored by Shu-ichi Ikeda

Since Specialization

Citations

This map shows the geographic impact of Shu-ichi Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-ichi Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-ichi Ikeda more than expected).

Fields of papers citing papers by Shu-ichi Ikeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu-ichi Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-ichi Ikeda. The network helps show where Shu-ichi Ikeda may publish in the future.

Co-authorship network of co-authors of Shu-ichi Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Shu-ichi Ikeda. A scholar is included among the top collaborators of Shu-ichi Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu-ichi Ikeda. Shu-ichi Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Late-onset spastic ataxia phenotype in a patient with a homozygous DDHD2 mutation 2014 ·Scientific Reports ·Hiroshi Doi,(unknown),Takashi Baba,Katsuko Tani,Masaaki Shiina,Kazuhiro Ogata,Satoko Miyatake,Y. Fukuda,Shoji Tsuji,Mitsuko Nakashima,Yoshinori Tsurusaki,Noriko Miyake,Hirotomo Saitsu,Shu-ichi Ikeda,Fumiaki Tanaka,(unknown),Kunihiro Yoshida	26
2	Guideline of transthyretin-related hereditary amyloidosis for cliniciansbreakdown → 2013 ·Orphanet Journal of Rare Diseases ·Yukio Ando,Teresa Coelho,John L. Berk,Márcia Waddington‐Cruz,Bo-Göran Ericzon,Shu-ichi Ikeda,W. David Lewis,Laura Obici,Violaine Planté‐Bordeneuve,Claudio Rapezzi,Gérard Saïd,Fabrizio Salvi	493
3	Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis 2013 ·Amyloid ·Elisabet Ihse,Claudio Rapezzi,Giampaolo Merlini,Merrill D. Benson,Yukio Ando,Ole B. Suhr,Shu-ichi Ikeda,Francesca Lavatelli,Laura Obici,Candida Cristina Quarta,Ornella Leone,Hirofumi Jono,Mitsuharu Ueda,Massimiliano Lorenzini,Juris J. Liepnieks,(unknown),Masayoshi Tasaki,Taro Yamashita,Per Westermark	107
4	Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis 2012 ·Amyloid ·Jean D. Sipe,Merrill D. Benson,Joel N. Buxbaum,Shu-ichi Ikeda,Giampaolo Merlini,Maria João Saraiva,Per Westermark	212
5	Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient 2012 ·BMJ Case Reports ·Konen Obayashi,Mitsuharu Ueda,Toshinori Oshima,(unknown),Yohei Misumi,Taro Yamashita,Hirofumi Jono,Masahide Yazaki,Fuyuki Kametani,Shu-ichi Ikeda,Yuki Ohya,Katsuhiro Asonuma,Yukihiro Inomata,Yukio Ando	10
6	Exome Sequencing Reveals a Homozygous SYT14 Mutation in Adult-Onset, Autosomal-Recessive Spinocerebellar Ataxia with Psychomotor Retardation 2011 ·The American Journal of Human Genetics ·Hiroshi Doi,Kunihiro Yoshida,Takao Yasuda,Mitsunori Fukuda,Y. Fukuda,Hiroshi Morita,Shu-ichi Ikeda,Rumiko Kato,Yoshinori Tsurusaki,Noriko Miyake,Hirotomo Saitsu,Haruya Sakai,Satoko Miyatake,Masaaki Shiina,Nobuyuki Nukina,Shigeru Koyano,Shoji Tsuji,Yoshiyuki Kuroiwa,Naomichi Matsumoto	57
7	Cerebral hemorrhage in Fabry's disease 2010 ·Journal of Human Genetics ·Katsuya Nakamura,Yoshiki Sekijima,Kimitoshi Nakamura,Kiyoko Hattori,(unknown),Yusaku Shimizu,(unknown),(unknown),Fumio Endo,Yoshimitsu Fukushima,Shu-ichi Ikeda	16
8	Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis 2010 ·Amyloid ·Jean D. Sipe,Merrill D. Benson,Joel N. Buxbaum,Shu-ichi Ikeda,Giampaolo Merlini,Maria João Saraiva,Per Westermark	243
9	The significance of carpal tunnel syndrome in transthyretin Val30Met familial amyloid polyneuropathy 2009 ·Amyloid ·Haruki Koike,Saori Morozumi,Yuichi Kawagashira,Masahiro Iijima,Masahiko Yamamoto,Naoki Hattori,Fumiaki Tanaka,Tomohiko Nakamura,Masaaki Hirayama,Yukio Ando,Shu-ichi Ikeda,Gen Sobue	28
10	Buerger's Disease Manifesting Nodular Erythema with Livedo Reticularis 2007 ·Internal Medicine ·(unknown),(unknown),Yasuaki Okuda,Masato Nose,Masayuki Matsuda,Shu-ichi Ikeda	4
11	Amyloid: Toward terminology clarification Report from the Nomenclature Committee of the International Society of Amyloidosis 2005 ·Amyloid ·Per Westermark,Merrill D. Benson,Joel N. Buxbaum,Alan S. Cohen,Blas Frangione,Shu-ichi Ikeda,Colin L. Masters,Giampaolo Merlini,Maria João Saraiva,Jean D. Sipe	248
12	Prevalence and clinical features of cough variant asthma in a general internal medicine outpatient clinic in Japan 2005 ·Respirology ·(unknown),Keisaku Fujimoto,Hiroko Arioka,(unknown),(unknown),Shu-ichi Ikeda	29
13	Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils 2004 ·FEBS Letters ·Xiaoying Fu,Tatsumi Korenaga,Li Fu,Yanming Xing,Zhanjun Guo,Takatoshi Matsushita,Masanori Hosokawa,Hironobu Naiki,Satoshi Baba,Yasushi Kawata,Shu-ichi Ikeda,Tokuhiro Ishihara,Masayuki Mori,Keiichi Higuchi	36
14	Multiple sclerosis with secondary syringomyelia 2001 ·Journal of the Neurological Sciences ·Masayuki Matsuda,Ken‐ichi Tabata,Jun Miki,(unknown),Masahiro Asano,Shu-ichi Ikeda	9
15	Abnormal activity in the globus pallidus in off-period dystonia 2001 ·Annals of Neurology ·Takao Hashimoto,Tsuyoshi Tada,(unknown),(unknown),(unknown),(unknown),Y Yamada,Shu-ichi Ikeda	12
16	Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan 1999 ·Brain ·K Misu,(unknown),Masaaki Nagamatsu,Shu-ichi Ikeda,Yukio Ando,Masamitsu Nakazato,Yo‐ichi Takei,Norinao Hanyu,(unknown),(unknown),Toshihide Harada,Akira Inukai,Yoshio Hashizume,Gen Sobue	142
17	Usefulness of MALDUTOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy 1999 ·Amyloid ·Naoko Tachibana,Takahiko Tokuda,Kunihiro Yoshida,Tamotsu Taketomi,M Nakazato,(unknown),Yoshiaki Masuda,Shu-ichi Ikeda	70
18	Recurrent steroid-responsive trismus and painful ophthalmoplegia 1999 ·Journal of the Neurological Sciences ·(unknown),Hiroyuki Yahikozawa,Masashi Yamazaki,(unknown),Shu-ichi Ikeda,Norinao Hanyu	2
19	On the occurrence of neuronal sprouting in the frontal cortex of a patient with Down's syndrome 1999 ·Acta Neuropathologica ·Shinji Ohara,(unknown),Shu-ichi Ikeda	5
20	Clinical Characteristics of Aged Becker Muscular Dystrophy Patients with Onset after 30 Years 1999 ·European Neurology ·Masahide Yazaki,Kunihiro Yoshida,Akinori Nakamura,Jun Koyama,Takashi Nanba,(unknown),Shu-ichi Ikeda	42

About Shu-ichi Ikeda

Shu-ichi Ikeda is a scholar working on Cell Biology, Physiology and Neurology, having authored 42 papers that have together received 3.1k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (23 papers), Alzheimer's disease research and treatments (10 papers) and Cellular transport and secretion (8 papers). The work is most often cited by research in Nephrology (408 citations), Molecular Biology (2.6k citations) and Physiology (956 citations). Shu-ichi Ikeda has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Merrill D. Benson, Giampaolo Merlini, Per Westermark, Maria João Saraiva, Joel N. Buxbaum, Jean D. Sipe, Yukio Ando, Gen Sobue, Blas Frangione and Colin L. Masters. Their work appears in journals such as Circulation, Brain and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact